BioPharma Dive18h
Bain buys Mitsubishi pharma unit; Bausch + Lomb deal talks come up empty
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
Japan Spectacle Lens Market To Worth Over US$ 5,764.09 Million By 2033 | Astute Analytica
Modern lifestyles, frequent prescription updates, and continuous lens enhancements drive Japan's spectacle lens market, promoting specialized designs ...
Bausch Health downgraded at Jefferies with B+L deal catalyst removed
Jefferies analyst Glen Santangelo downgraded Bausch Health (BHC) to Hold from Buy with a price target of $8, down from $12, after the company ...
Contact lens maker Bausch + Lomb rules out going private at this time
Bausch + Lomb will not be taken private at this time, the contact lens maker said on Thursday, sending its U.S.-listed shares ...
Contact lens maker Bausch + Lomb rules out take-private deal
(Reuters) -Bausch + Lomb will not be taken private at this time, the contact lens maker said on Thursday. In December, the ...